Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Long-term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation Therapy Oncology Group.
Perez CA, Pajak TF, Rubin P, Simpson JR, Mohiuddin M, Brady LW, Perez-Tamayo R, Rotman M. Perez CA, et al. Among authors: rotman m. Cancer. 1987 Jun 1;59(11):1874-81. doi: 10.1002/1097-0142(19870601)59:11<1874::aid-cncr2820591106>3.0.co;2-z. Cancer. 1987. PMID: 3032394 Clinical Trial.
Impact of irradiation technique and tumor extent in tumor control and survival of patients with unresectable non-oat cell carcinoma of the lung: report by the Radiation Therapy Oncology Group.
Perez CA, Stanley K, Grundy G, Hanson W, Rubin P, Kramer S, Brady LW, Marks JE, Perez-Tamayo R, Brown GS, Concannon JP, Rotman M. Perez CA, et al. Among authors: rotman m. Cancer. 1982 Sep 15;50(6):1091-9. doi: 10.1002/1097-0142(19820915)50:6<1091::aid-cncr2820500612>3.0.co;2-0. Cancer. 1982. PMID: 6286087 No abstract available.
A prospective randomized study of various irradiation doses and fractionation schedules in the treatment of inoperable non-oat-cell carcinoma of the lung. Preliminary report by the Radiation Therapy Oncology Group.
Perez CA, Stanley K, Rubin P, Kramer S, Brady L, Perez-Tamayo R, Brown GS, Concannon J, Rotman M, Seydel HG. Perez CA, et al. Among authors: rotman m. Cancer. 1980 Jun 1;45(11):2744-53. doi: 10.1002/1097-0142(19800601)45:11<2744::aid-cncr2820451108>3.0.co;2-u. Cancer. 1980. PMID: 6991092 Clinical Trial. No abstract available.
The prognostic significance of race and survival from prostate cancer based on patients irradiated on Radiation Therapy Oncology Group protocols (1976-1985).
Roach M 3rd, Krall J, Keller JW, Perez CA, Sause WT, Doggett RL, Rotman M, Russ H, Pilepich MV, Asbell SO, et al. Roach M 3rd, et al. Among authors: rotman m. Int J Radiat Oncol Biol Phys. 1992;24(3):441-9. doi: 10.1016/0360-3016(92)91058-u. Int J Radiat Oncol Biol Phys. 1992. PMID: 1399729 Clinical Trial.
A report of RTOG 8206: a phase III study of whether the addition of single dose hemibody irradiation to standard fractionated local field irradiation is more effective than local field irradiation alone in the treatment of symptomatic osseous metastases.
Poulter CA, Cosmatos D, Rubin P, Urtasun R, Cooper JS, Kuske RR, Hornback N, Coughlin C, Weigensberg I, Rotman M. Poulter CA, et al. Among authors: rotman m. Int J Radiat Oncol Biol Phys. 1992;23(1):207-14. doi: 10.1016/0360-3016(92)90563-w. Int J Radiat Oncol Biol Phys. 1992. PMID: 1374061 Clinical Trial.
Influence of location and extent of surgical resection on survival of patients with glioblastoma multiforme: results of three consecutive Radiation Therapy Oncology Group (RTOG) clinical trials.
Simpson JR, Horton J, Scott C, Curran WJ, Rubin P, Fischbach J, Isaacson S, Rotman M, Asbell SO, Nelson JS, et al. Simpson JR, et al. Among authors: rotman m. Int J Radiat Oncol Biol Phys. 1993 May 20;26(2):239-44. doi: 10.1016/0360-3016(93)90203-8. Int J Radiat Oncol Biol Phys. 1993. PMID: 8387988 Clinical Trial.
255 results